论文部分内容阅读
目的:观察升血汤在进展期胃癌综合治疗的作用。方法:将86例进展期胃癌患者随机分成两组,观察组45例升血汤联合化疗,对照组41例单纯化疗。结果:观察组总有效率62.1%,对照组总有效率为42.6%,观察组高于对照组(P<0.05);观察组患者的不良反应明显轻于对照组。结论:升血汤联合化疗能提高患者对化疗的耐受性,改善生活质量,提高免疫力的作用。
Objective: To observe the role of Sheng Xue Tang in the treatment of advanced gastric cancer. Methods: Eighty-six patients with advanced gastric cancer were randomly divided into two groups. In the observation group, 45 cases were treated with Shengxue Decoction combined with chemotherapy, while the control group with 41 cases with simple chemotherapy. Results: The total effective rate was 62.1% in the observation group and 42.6% in the control group, and the observation group was higher than the control group (P <0.05). The adverse reactions in the observation group were obviously lighter than those in the control group. Conclusion: Sheng Xue Tang combined with chemotherapy can improve patient tolerance to chemotherapy, improve quality of life, improve immunity.